Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22873530 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550;   Drug: Placebo
2 Recruiting Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: CP-690,550;   Drug: Methotrexate;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.